UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

The New England journal of medicine, 2016-12, Vol.375 (24), p.2335-2348

2016

Volltextzugriff (PDF)

Interleukin 17A: Toward a new understanding of psoriasis pathogenesis

Journal of the American Academy of Dermatology, 2014-07, Vol.71 (1), p.141-150

2014

Volltextzugriff (PDF)

Off-Label Use of Topical Calcineurin Inhibitors in Dermatologic Disorders

Journal of cutaneous medicine and surgery, 2019-09, Vol.23 (4_suppl), p.27S-34S

2019

Volltextzugriff (PDF)

Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled study

Journal of the American Academy of Dermatology, 2017-01, Vol.76 (1), p.33-39

2017

Volltextzugriff (PDF)

Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL

Journal of the American Academy of Dermatology, 2012-02, Vol.66 (2), p.241-251

2012

Volltextzugriff (PDF)

Review of Systemic Treatment Options for Adult Atopic Dermatitis

Journal of Cutaneous Medicine and Surgery, 2017-01, Vol.21 (1), p.31-39

2017

Volltextzugriff (PDF)

Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial

Acta dermato-venereologica, 2020-01, Vol.100 (1), p.adv00006-9

2020

Volltextzugriff (PDF)

Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell Carcinoma

Journal of cutaneous medicine and surgery, 2015-05, Vol.19 (3), p.249-259

2015

Volltextzugriff (PDF)

Canadian Clinical Practice Guidelines for Rosacea

Journal of Cutaneous Medicine and Surgery, 2016-09, Vol.20 (5), p.432-445

2016

Volltextzugriff (PDF)

Real-World Experience With Apremilast in the Treatment of Adults With Moderate to Severe Plaque Psoriasis in Québec: A Claims-Based Analysis of Drug Utilization and Healthcare Resource Utilization

Journal of cutaneous medicine and surgery, 2020-11, Vol.24 (6), p.573-587

2020

Volltextzugriff (PDF)

Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population

Journal of the American Academy of Dermatology, 2012-02, Vol.66 (2), p.e33-e45

2012

Volltextzugriff (PDF)

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section IV: Treatment Options for the Management of Atopic Dermatitis

Journal of cutaneous medicine and surgery, 2018-11, Vol.22 (1_suppl), p.21S-29S

2018

Volltextzugriff (PDF)

Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper

Journal of cutaneous medicine and surgery, 2020-07, Vol.24 (1_suppl), p.3S-14S

2020

Volltextzugriff (PDF)

Canadian Guidelines for the Management of Plaque Psoriasis: Overview

Journal of cutaneous medicine and surgery, 2011-07, Vol.15 (4), p.210-219

2011

Volltextzugriff (PDF)

Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document

Journal of Cutaneous Medicine and Surgery, 2017-11, Vol.21 (6), p.513-524

2017

Volltextzugriff (PDF)

A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in Adults

Journal of Cutaneous Medicine and Surgery, 2018-01, Vol.22 (1), p.78-83

2018

Volltextzugriff (PDF)

Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris

Journal of the American Academy of Dermatology, 2007-03, Vol.56 (3), p.439.e1-439.e10

2007

Volltextzugriff (PDF)

Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II

Frontiers in medicine, 2022-03, Vol.9, p.821871-821871

2022

Volltextzugriff (PDF)

Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses

Journal of cutaneous medicine and surgery, 2015-05, Vol.19 (3), p.227-238

2015

Volltextzugriff (PDF)

North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations

Journal of the American Academy of Dermatology, 2019-07, Vol.81 (1), p.91-101

2019

Volltextzugriff (PDF)

North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations

Journal of the American Academy of Dermatology, 2019-07, Vol.81 (1), p.76-90

2019

Volltextzugriff (PDF)

Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study

Journal of the American Academy of Dermatology, 2011-04, Vol.64 (4), p.671-681

2011

Volltextzugriff (PDF)

Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi Study

Journal of cutaneous medicine and surgery, 2019-05, Vol.23 (3), p.282-288

2019

Volltextzugriff (PDF)

A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab

Frontiers in medicine, 2021-08, Vol.8, p.702776-702776

2021

Volltextzugriff (PDF)

Correction to: Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel

Dermatology and therapy, 2023-08, Vol.13 (8), p.1891-1892

2023

Volltextzugriff (PDF)

1 – 25 von 261

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(227)
Mit Volltextzugriff
(235)

Publikationsform

Sprache

Englisch
(250)
Französisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

Interleukin 17A: Toward a new understanding of psoriasis pathogenesis

Off-Label Use of Topical Calcineurin Inhibitors in Dermatologic Disorders

Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled study

Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL

Review of Systemic Treatment Options for Adult Atopic Dermatitis

Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial

Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell Carcinoma

Canadian Clinical Practice Guidelines for Rosacea

Real-World Experience With Apremilast in the Treatment of Adults With Moderate to Severe Plaque Psoriasis in Québec: A Claims-Based Analysis of Drug Utilization and Healthcare Resource Utilization

Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section IV: Treatment Options for the Management of Atopic Dermatitis

Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper

Canadian Guidelines for the Management of Plaque Psoriasis: Overview

Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document

A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in Adults

Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris

Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II

Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses

North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations

North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations

Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study

Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi Study

A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab

Correction to: Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel

Suchergebnisse filtern